Daniel Keszthelyi
Daniel Keszthelyi
Maastricht University Medical Center
Potvrđena adresa e-pošte na maastrichtuniversity.nl
Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function
D Keszthelyi, FJ Troost, AAM Masclee
Neurogastroenterology & Motility 21 (12), 1239-1249, 2009
Leaky gut and diabetes mellitus: what is the link?
S De Kort, D Keszthelyi, AAM Masclee
Obesity Reviews 12 (6), 449-458, 2011
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome
D Keszthelyi, FJ Troost, AA Masclee
American Journal of Physiology-Gastrointestinal and Liver Physiology 303 (2 …, 2012
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case–control study
D Keszthelyi, SV Jansen, GA Schouten, S De Kort, B Scholtes, L Engels, ...
Alimentary pharmacology & therapeutics 32 (9), 1124-1128, 2010
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to …
Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ...
Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014
Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff
S Ludidi, JM Conchillo, D Keszthelyi, M Van Avesaat, JW Kruimel, ...
Neurogastroenterology & Motility 24 (8), 729-e346, 2012
Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice
Z Helyes, E Pintér, K Sándor, K Elekes, Á Bánvölgyi, D Keszthelyi, ...
Proceedings of the National Academy of Sciences 106 (31), 13088-13093, 2009
Effects of the somatostatin receptor subtype 4 selective agonist J‐2156 on sensory neuropeptide release and inflammatory reactions in rodents
Z Helyes, E Pinter, J Nemeth, K Sándor, K Elekes, A Szabo, G Pozsgai, ...
British journal of pharmacology 149 (4), 405-415, 2006
Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
D Keszthelyi, FJ Troost, DM Jonkers, Z Helyes, HM Hamer, S Ludidi, ...
European Journal of Pain 17 (9), 1299-1306, 2013
Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat
B Jakab, Z Helyes, A Varga, K Bölcskei, Á Szabó, K Sándor, K Elekes, ...
European journal of pharmacology 517 (1-2), 35-44, 2005
Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach
E Elamin, A Masclee, F Troost, HJ Pieters, D Keszthelyi, K Aleksa, ...
PloS one 9 (9), 2014
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
AV Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ...
Science translational medicine 10 (472), eaap8914, 2018
MIP-based biomimetic sensor for the electronic detection of serotonin in human blood plasma
M Peeters, FJ Troost, B van Grinsven, F Horemans, J Alenus, MS Murib, ...
Sensors and Actuators B: Chemical 171, 602-610, 2012
Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012
BPM Verhaegh, DMAE Jonkers, A Driessen, MP Zeegers, D Keszthelyi, ...
Digestive and Liver Disease 47 (1), 30-36, 2015
Revisiting concepts of visceral nociception in irritable bowel syndrome
D Keszthelyi, FJ Troost, M Simrén, S Ludidi, JW Kruimel, JM Conchillo, ...
European journal of pain 16 (10), 1444-1454, 2012
Does acute tryptophan depletion affect peripheral serotonin metabolism in the intestine?
D Keszthelyi, FJ Troost, DM Jonkers, EL van Donkelaar, J Dekker, ...
The American journal of clinical nutrition 95 (3), 603-608, 2012
Is microscopic colitis a drug-induced disease?
D Keszthelyi, J Penders, AA Masclee, M Pierik
Journal of clinical gastroenterology 46 (10), 811-822, 2012
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
S Ludidi, Z Mujagic, D Jonkers, D Keszthelyi, M Hesselink, J Kruimel, ...
Neurogastroenterology & Motility 26 (8), 1104-1111, 2014
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study
L Vork, Z Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ...
Neurogastroenterology & Motility 30 (2), e13189, 2018
Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state
D Keszthelyi, FJ Troost, DM Jonkers, JW Kruimel, C Leue, AAM Masclee
Journal of psychosomatic research 74 (6), 501-504, 2013
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20